• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Relative bioavailability of two different phenytoin preparations. Evidence for an age dependency.

作者信息

Matsukura M, Ikeda T, Higashi A, Matsuda I

出版信息

Dev Pharmacol Ther. 1984;7(3):160-8. doi: 10.1159/000457159.

DOI:10.1159/000457159
PMID:6723491
Abstract

Relative bioavailability (RB) of two commercially available phenytoin preparations showed greater differences in absorption in children than in adults. 93 patients received one or more doses of one or two preparations. Serum assays were made at steady state. Age-matched groups were compared. In another cross-over study, 12 patients received two or more doses of each formulation until steady state levels were reached. 5 adult volunteers received single doses of each preparation, and multiple serum samples were assayed to define the peak blood concentration and area under the curve. To calculate RB, the value of V max/F was determined from plots of serum concentration (C) vs. C/dose (C/D). Bioavailability was greater in the preparation with the smaller crystal size and more rapid in vitro dissolution. Relative bioavailability increased with increasing age, suggesting an age-dependent effect on drug absorption.

摘要

相似文献

1
Relative bioavailability of two different phenytoin preparations. Evidence for an age dependency.
Dev Pharmacol Ther. 1984;7(3):160-8. doi: 10.1159/000457159.
2
Effect of formulation on dissolution and bioavailability of phenytoin tablets.剂型对苯妥英钠片溶出度和生物利用度的影响。
Pharmazie. 1980;35(10):627-9.
3
[Dissolution rates and bioavailability of phenytoin preparations (author's transl)].
Arzneimittelforschung. 1979;29(3):552-5.
4
Factors affecting the bioavailability of phenytoin.影响苯妥英生物利用度的因素。
Int J Clin Pharmacol Biopharm. 1977 Feb;15(2):84-9. doi: 10.103/00006450-11000-00005.
5
A comparison between microcrystalline and conventional phenytoin preparations: relative bioavailability and steady-state plasma concentrations.
J Neurol. 1980;223(4):241-9. doi: 10.1007/BF00313338.
6
Oral phenytoin in infancy: dose requirement, absorption, and elimination.婴儿期口服苯妥英钠:剂量需求、吸收与消除
Pediatr Pharmacol (New York). 1983;3(3-4):229-36.
7
Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children.
Ther Drug Monit. 1984;6(1):11-4.
8
Bioavailability of phenytoin: clinical pharmacokinetic and therapeutic implications.苯妥英钠的生物利用度:临床药代动力学及治疗意义
Clin Pharmacokinet. 1979 Mar-Apr;4(2):91-103. doi: 10.2165/00003088-197904020-00002.
9
Effect of doses on the bioavailability of phenytoin from a prompt-release and an extended-release preparation: single dose study.剂量对速释和缓释制剂中苯妥英生物利用度的影响:单剂量研究。
J Med Assoc Thai. 2007 Sep;90(9):1883-93.
10
A comparative study of the bioavailability of five different phenytoin preparations.五种不同苯妥英制剂生物利用度的比较研究。
J Pharm Pharmacol. 1985 Aug;37(8):570-2. doi: 10.1111/j.2042-7158.1985.tb03070.x.

引用本文的文献

1
Development of a Pediatric Relative Bioavailability/Bioequivalence Database and Identification of Putative Risk Factors Associated With Evaluation of Pediatric Oral Products.建立儿科相对生物利用度/生物等效性数据库并确定与儿科口服制剂评估相关的潜在风险因素。
AAPS J. 2021 Apr 21;23(3):57. doi: 10.1208/s12248-021-00592-y.
2
Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.抗癫痫药物在儿科患者中的临床药代动力学。第二部分。苯妥英、卡马西平、舒噻美、拉莫三嗪、氨己烯酸、奥卡西平和非氨酯。
Clin Pharmacokinet. 1995 Nov;29(5):341-69. doi: 10.2165/00003088-199529050-00004.